Elicio Therapeutics, Inc. (ELTX) SEC Filings — 2025
15 SEC filings for Elicio Therapeutics, Inc. (ELTX) in 2025.
Filings
- Elicio Narrows Losses, Boosts Cash Amid R&D Spend Cuts — 10-Q · Nov 13, 2025
- Elicio Therapeutics Files 8-K — 8-K · Sep 17, 2025
- Elicio Therapeutics Files 8-K — 8-K · Aug 12, 2025
- Elicio Therapeutics Reports No Revenue, Continues R&D Spend — 10-Q · Aug 7, 2025
- Elicio Therapeutics Files 8-K — 8-K · Aug 5, 2025
- Elicio Therapeutics Files 8-K: Material Agreement, Debt, Equity Sales — 8-K · Jun 4, 2025
- Elicio Therapeutics Files 8-K on Shareholder Matters — 8-K · May 20, 2025
- Elicio Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Elicio Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 9, 2025
- Elicio Therapeutics, Inc. 10-K Filing — 10-K · Mar 31, 2025
- Elicio Therapeutics Reports Officer and Director Changes — 8-K · Mar 24, 2025
- Elicio Therapeutics Files 8-K on Equity Sales — 8-K · Mar 5, 2025
- Elicio Therapeutics Enters Material Definitive Agreement — 8-K · Jan 30, 2025
- Elicio Therapeutics Files 8-K — 8-K · Jan 23, 2025
- Elicio Therapeutics Files 8-K — 8-K · Jan 22, 2025